Edgewise Therapeutics Inc. Common Stock vs Hudbay Minerals Inc. Ordinary Shares (Canada) — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.04 (market cap $3.94B), while Hudbay Minerals Inc. Ordinary Shares (Canada) trades at $23.91 (market cap $11.37B). The key difference: Hudbay Minerals Inc. Ordinary Shares (Canada) is far larger — about 2.9× Edgewise Therapeutics Inc. Common Stock's market cap, and Hudbay Minerals Inc. Ordinary Shares (Canada) pays a 0.11% dividend while Edgewise Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Hudbay Minerals Inc. Ordinary Shares (Canada) for 6 Days on average.
| EWTX | HBM | |
|---|---|---|
Market Cap | $3.94B | $11.37B |
Volume | 810,104 | 3,520,423 |
Sector | Health | Basic Materials |
52-Week High | $48.35 | $31.87 |
52-Week Low | $14.89 | $14.58 |
Typical Hold Time | 0 Days | 6 Days |
Enterprise Value | $3.48B | $11.43B |
Dividend Yield | — | 0.11% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
HudBay Minerals (HBM) trades at $25.68, down 0.31% with bearish technical signals despite solid fundamentals. The company reported strong 2025 results with $2.21B revenue and $568.5M net income, while analyst consensus remains positive with 60% buy ratings. Recent news highlights HBM4 equipment delays and copper/gold reserve expansions at Snow Lake operations.
HBM presents a value opportunity with reasonable valuation (P/E 15.77) and strong profitability (ROE 18.43%), though technical weakness and HBM market dynamics pose near-term risks. The stock's outlook depends on execution of copper growth strategy and resolution of memory sector supply chain concerns.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →Hudbay Minerals is a mining company producing copper, gold, zinc, and other metals. Its operations are located in the Americas.
Read more on HBM →